Simona Soverini, PhD, stopped by the Society of Hematologic Oncology booth at the 64th American Society of Hematology Annual Meeting and Exposition to discuss chronic myeloid leukemia (CML), including treatment advances, new molecular data on CML, remaining challenges, and potentially practice-changing ASH abstracts.